Replicate Bioscience, a company pioneering novel self-replicating RNA (srRNA) technology for use in infectious disease, oncology, and autoimmune disease, has appointed Rachael Lester Chief Business Officer. Lester, who has more than 20 years of experience as a senior executive in the biopharmaceutical industry, will be responsible for leading corporate strategy, business development, portfolio strategy, and new product planning. Lester joins Replicate from Harpoon Therapeutics, a clinical-sta...